Inhibition of RNA transcription: A biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine

Leukemia

Volumn 14, Issue 8, 2000, Pages 1405-1413

  Huang, P ^a   Sandoval, A ^a   Van Den Neste, E ^a   Keating, M J ^a   Plunkett, W ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Chronic lymphocytic leukemia; Fludarabine; Protein; RNA

Indexed keywords

AMANITIN; APHIDICOLIN; CELL PROTEIN; DACTINOMYCIN; DNA; FLUDARABINE; GEMCITABINE; MESSENGER RNA; NUCLEOTIDE DERIVATIVE; PROTEIN SYNTHESIS INHIBITOR; PUROMYCIN; RNA; VIDARABINE; ZALCITABINE;

ARTICLE; BIOCHEMISTRY; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RNA SYNTHESIS; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION;

EID: 0033902940     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401845     Document Type: Article

References (42)

1. Molecular biology of chronic lymphocytic leukemia
2. Chronic lymphocytic leukemia
3. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy
4. Clinical experience with fludarabine in hemato-oncology
5. Fludarabine: An update of its pharmacology and use in the treatment of haematological malignancies
6. Fludarabine phosphate: A new active agent in hematologic malignancies
7. Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia
8. Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: Five-year follow-up report
9. Termination of DNA synthesis by 9-β-D-arabinofuranosyl-2-fluoroadenine: A mechanism for cytotoxicity
10. Fludarabine and gemcitabine-induced apoptosis: Incorporation of analogs into DNA is a critical event
11. High molecular weight DNA fragmentation: A critical event in nucleoside analogue-induced apoptosis in leukemia cells
12. Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug-induced apoptosis
13. Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase
14. Primer RNA chain termination induced by 9-β-D-arabinofuranosyl-2-fluoroadenine 5'-triphosphate: A mechanism of DNA synthesis inhibition
15. Dual mode of inhibition of purified DNA ligase I from human cells by 9-β-D-arabinofuranosyl-2-fluoroadenine triphosphate
16. Action of 9-β-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism
17. Chronic lymphocytic leukemia: New insights into biology and therapy
18. Chronic lymphocytic leukemia: An updated review
19. Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute-sponsored working group
20. Functional compartmentation of dCTP pools: Preferential utilization of salvaged deoxycytidine for DNA repair in human lymphoblasts
21. Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells
22. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine
23. Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases beta and gamma
24. Overexpression of DNA polymerase beta sensitizes mammalian cells to 2',3'-deoxycytidine and 3'-azido-3'-deoxythymidine
25. Action of 2',2'-difluorodeoxycytidine on DNA synthesis
26. Sequence-specific inhibition of RNA elongation by actinomycin D
27. Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro
28. Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes
29. Arabinosylfluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair
30. Incorporation of 9-β-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA
31. Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway
32. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs
33. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: Relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance
34. 2-Chlorodeoxyadenosine: A newer purine analog active in the treatment of indolent lymphoid malignancies
35. Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells
36. Incorporation of 2-halogen-2'-deoxyadenosine 5-triphosphates into DNA during replication by human polymerases alpha and beta
37. In vitro transcription of DNA containing 2-chloro-2'-deoxyadenosine monophosphate
38. Inhibition of IL-2 production mediates fludarabine-induced suppression of normal human T cell activation leading to apoptosis
39. Effect of cycloheximide on B-chronic lymphocytic leukemic and normal lymphocytes in vitro: Induction of apoptosis
40. Clinical evaluation of puromycin in human neoplastic disease
41. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells
42. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia